These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33239128)

  • 1. Effect of aluminium ion on bioavailability of levofloxacin following oral administration of cilexetil ester of levofloxacin as prodrug in rats.
    Shinmachi K; Takahashi Y; Kaneuji Y; Kawamura R; Kohama K; Hieda Y; Goromaru T; Eto S; Murakami T; Maeda Y
    Pharmazie; 2020 Nov; 75(11):554-558. PubMed ID: 33239128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of hemiacetal esterified levofloxacin to prevent chelation with metal-containing drugs.
    Otori T; Matzno S; Kawase A; Iwaki M; Kimachi T; Nishiwaki K; Figoni WC; Tominaga R; Asahide M; Nishikata M; Ishii Y; Matsuyama K
    J Pharm Pharmacol; 2016 Dec; 68(12):1527-1534. PubMed ID: 27774590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of a Prodrug of Levofloxacin to Avoid Chelation with Al
    Matsuyama K
    Yakugaku Zasshi; 2017; 137(9):1087-1094. PubMed ID: 28867695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of aluminium-containing antacid on bioavailability of ofloxacin following oral administration of pivaloyloxymethyl ester of ofloxacin as prodrug.
    Maeda Y; Omoda K; Konishi T; Takahashi M; Kihira K; Hibino S; Tsukiai S
    Biol Pharm Bull; 1993 Jun; 16(6):594-9. PubMed ID: 8364513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herb-drug interactions: Quantitative analysis of levofloxacin absorption and transporter expression in the rat intestine following combined treatment with Persicaria capitata (Buch.-Ham. ex D. Don) H. Gross.
    Zhou Y; Chi M; Zhou Z; Wang L; Yuan L; Zheng L; Huang Y
    J Pharm Biomed Anal; 2024 Aug; 245():116156. PubMed ID: 38636190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antibacterial activity of levofloxacin eye drops against staphylococci using an in vitro pharmacokinetic model in the bulbar conjunctiva.
    Suzuki T; Yamamoto T; Ohashi Y
    J Infect Chemother; 2016 Jun; 22(6):360-5. PubMed ID: 27036073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic study of inhibition of levofloxacin absorption by aluminum hydroxide.
    Tanaka M; Kurata T; Fujisawa C; Ohshima Y; Aoki H; Okazaki O; Hakusui H
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2173-8. PubMed ID: 8257141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation by Monte Carlo simulation of levofloxacin dosing for complicated urinary tract infections caused by Escherichia coli or Pseudomonas aeruginosa.
    Deguchi T; Seike K; Yasuda M; Matsumoto T
    J Infect Chemother; 2011 Oct; 17(5):726-30. PubMed ID: 21409530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo antibacterial activity of levofloxacin against Escherichia coli and its pharmacokinetic profile following intravenous and oral administrations in broilers.
    Lee HK; DeVito V; Vercelli C; Tramuta C; Nebbia P; Re G; Kovalenko K; Giorgi M
    Res Vet Sci; 2017 Jun; 112():26-33. PubMed ID: 28113087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrapulmonary concentration of levofloxacin in patients with idiopathic pulmonary fibrosis.
    Huang H; Wang Y; Jiang C; Lang L; Wang H; Chen Y; Zhao Y; Xu Z
    Pulm Pharmacol Ther; 2014 Jun; 28(1):49-52. PubMed ID: 24211813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro short-term bactericidal activity and accumulation of NM394, the active metabolite of prulifloxacin, for Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa: comparison with ciprofloxacin, levofloxacin, and gatifloxacin].
    Shimizu M; Tabata M; Hara T; Araake M; Watabe H; Nishino T
    Jpn J Antibiot; 2002 Dec; 55(6):791-9. PubMed ID: 12621733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of oral levofloxacin and sitafloxacin in epididymal tissue.
    Sadahira T; Wada K; Ikawa K; Morikawa N; Kurahashi H; Yoshioka T; Ariyoshi Y; Kobayashi Y; Araki M; Ishii A; Watanabe M; Uehara S; Watanabe T; Nasu Y
    J Infect Chemother; 2017 Apr; 23(4):214-217. PubMed ID: 28089362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population Pharmacokinetics and Pharmacodynamics of Levofloxacin in Acutely Hospitalized Older Patients with Various Degrees of Renal Function.
    Cojutti PG; Ramos-Martin V; Schiavon I; Rossi P; Baraldo M; Hope W; Pea F
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population Pharmacokinetics and Pharmacodynamics Modeling of Oral Levofloxacin.
    Jaruratanasirikul S; Jaspattananon A; Wongpoowarak W; Nawakitrangsan M; Thengyai S; Samaeng M
    J Med Assoc Thai; 2018 Aug; 99(8):886-92. PubMed ID: 29947489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bactericidal effect of levofloxacin injection in combination with meropenem against Pseudomonas aeruginosa using an in vitro simulation model with a hollow fiber system].
    Uoyama S; Kanda H; Yoshida K; Hoshino K
    Jpn J Antibiot; 2012 Dec; 65(6):355-63. PubMed ID: 23593732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability and pharmacokinetic profile of levofloxacin following intravenous, intramuscular and oral administration in turkeys.
    Aboubakr M; Uney K; Elmas M
    Br Poult Sci; 2014 Feb; 55(1):115-9. PubMed ID: 24735473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics of levofloxacin in Korean patients.
    Kiem S; Ryu SM; Lee YM; Schentag JJ; Kim YW; Kim HK; Jang HJ; Joo YD; Jin K; Shin JG; Ghim JL
    J Chemother; 2016 Aug; 28(4):308-13. PubMed ID: 25976699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bactericidal effect of levofloxacin on strains with equal susceptibility in an in vitro urinary bladder model.
    Takahashi S; Sano M; Nishimura M; Matsukawa M; Mikami M; Hirose T; Tsukamoto T
    Chemotherapy; 1998; 44(5):337-42. PubMed ID: 9732150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of bile duct ligation and unilateral nephrectomy on brain concentration and convulsant potential of the quinolone antibacterial agent levofloxacin in rats.
    Akahane K; Ohkawara S; Nomura M; Kato M
    Fundam Appl Toxicol; 1996 Feb; 29(2):280-6. PubMed ID: 8742326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of levofloxacin following oral administration of a generic levofloxacin tablet and intravenous administration to dogs.
    Madsen M; Messenger K; Papich MG
    Am J Vet Res; 2019 Oct; 80(10):957-962. PubMed ID: 31556716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.